6 Questions to Ask a Medtech Marketing Agency First

Key Takeaways

• Most agencies that brand themselves as medtech marketing specialists run digital campaigns, not market engineering; knowing the vocabulary is not the same as understanding commercialization
• Clinical champion development and push-driven marketing are opposite strategies; an agency that conflates them will attempt to scale before the market is engineered
• The traction gap, the period between FDA clearance and commercial traction, is invisible to most marketing agencies and visible to every real one
• A market narrative is the belief architecture that makes a market ready to receive a product, and a content calendar is not a market narrative
• After 370+ State of MedTech episodes, every founder who built a significant exit said the market was engineered years before the deal room

A medtech marketing agency that understands commercialization can answer six questions without hesitation: whether they've worked pre-traction, how they distinguish clinical champion development from push-driven marketing, what they know about VAC and IDN procurement, what the traction gap means, how they build market narratives versus campaign assets, and how their work sequences with market engineering.

An agency that can't answer all six isn't a medtech specialist. It's a healthcare digital shop.

Watch the full episode on YouTube

Why Most Medtech Marketing Agencies Are Healthcare Digital Shops With Medtech Vocabulary

You search "medtech marketing agency." You find firms that speak your language. VAC, 510(k), KOL strategy, GPO contracting. Their case studies mention device commercialization. Their team bios list hospital sales experience.

And you sign.

Six months later, you have brand assets, a content calendar, and LinkedIn impressions. But you don't have clinical traction. Investors still tell you to come back when you have more traction. And you're running out of time before your next raise.

This is the digital shop trap. And it catches most medtech founders.

I covered this pattern on an episode about medtech commercialization and the GTM discipline gap. I was talking with Fazila Seker, CEO of Insight Medbotics, when I said:

"We don't have that same level of discipline when it comes to our go to market and market engineering. Founders skip over that. I talked to a company just like two or three weeks ago they've been commercial for like three years and I'm like, man, that's going to be really rough when you guys go back to raise."

The same gap exists between a healthcare digital shop and a real medtech marketing agency. One knows the vocabulary. The other knows the commercialization architecture behind it.

When I interviewed Neil Patel on an episode about digital marketing and agency positioning, he made the baseline case clearly:

"Focus on a vertical like Medtech or e-commerce. It's too competitive to be a general agency."

Vertical focus is the starting requirement. But it's not sufficient. The question is whether the focus runs deep enough to include understanding of market-product fit, the traction gap, and the role of market engineering before the sales team scales.

The 6 Questions That Separate a Real Medtech Marketing Agency From a Digital Shop

These questions aren't gotchas. They're diagnostic. A real agency answers them immediately and in detail. A digital shop hedges, reframes, or changes the subject.

Question 1: Have you worked with a company before commercial traction?

Pre-traction work is structurally different from post-Series B marketing. Pre-traction means the market category doesn't exist yet. You're not promoting a known device into an established market.

You're engineering a category that will make the device seem inevitable to surgeons, hospitals, and investors.

An agency that's only worked post-traction has never built from zero. They know how to scale. But the engineering part is different.

Question 2: How do you define the difference between clinical champion development and push-driven marketing?

Clinical champion development seeds conviction in specific early adopters, the surgeons, interventionalists, or proceduralists who carry credibility through institutional networks. Push-driven marketing broadcasts to a broad audience that hasn't yet formed a belief about the device's category.

Most agencies default to the push approach. The traction gap lives in the space they skip.

I covered this distinction on an episode about medtech adoption and crossing the chasm:

"Early adopters, they buy possibility. Early majority, they buy category clarity. If your category is not clear, the market's just not going to engage."

The agency that understands this builds conviction before building volume. The agency that doesn't pushes volume before conviction exists.

Question 3: Have you navigated VAC and IDN procurement?

Value analysis committees and IDNs add 6 to 18 months to commercial cycles. A real medtech marketing agency has mapped procurement decision trees, built economic buyer content for hospital administrators, and created physician-to-administrator pathways that move a device from clinical interest to budget approval.

An agency that's never produced content for a value analysis committee doesn't understand how medtech sales close.

Question 4: What is the traction gap and how do you address it?

The traction gap is the period between clinical validation and commercial traction. A device can have FDA clearance, Phase III data, KOL endorsements, and enthusiastic physician feedback, and still stall completely in the traction gap because the market narrative isn't built.

If an agency hasn't heard this term, they haven't read the playbook. If they've heard it but can't describe their approach to crossing it, they're citing vocabulary they don't use.

Question 5: How do you build a market narrative?

A market narrative is not a content calendar or a brand story. It's the belief architecture that makes the market ready to receive the product before the sales team scales.

I described the engineering behind this on an episode about pre-commercial market engineering in medtech:

"Markets don't form after launch, they form before it. And in medtech, they don't just form on their own. They have to be crafted and engineered. Nobody finds you in medtech, you engineer being found."

An agency that answers "we tell your story" is describing content marketing. An agency that answers with sequenced conviction phases, ecosystem narrative building, and clinical-to-commercial handoffs is describing market engineering. Those are different disciplines.

Question 6: How does your work sequence against market engineering?

Market engineering has phases. Clinical conviction comes before commercial conviction. Economic buyer content comes before volume commitments. Physician network seeding happens before the field sales team scales.

A real medtech marketing agency shows you a sequenced roadmap that mirrors how medtech markets form. A digital shop shows you an integrated campaign deck.

Ask them to show you the sequence. Watch how they react.

What the Wrong Medtech Marketing Agency Costs a Founder

The retainer cost is visible. Usually $10,000 to $30,000 per month for a medtech-positioned agency. But the real cost is the 6 to 12 months of runway you burn while the agency runs campaigns that don't build commercial conviction.

Investors are watching. "Come back when you have more traction" is not a fundraising problem. It's a market architecture problem that the wrong agency made worse.

For the full picture of what that costs, see how hiring a healthcare marketing agency before defining your category affects your medtech runway.

The market-product fit question, whether the market is ready for your product rather than whether your product fits a market, is what these six questions are designed to probe. An agency that can't engage with that question at a diagnostic level isn't equipped to help you cross the traction gap.

What This Means for Medtech Founders

In my experience working with medtech founders and commercial leaders, the agency selection mistake is almost always made the same way.

The founder types "medtech marketing agency" into Google, talks to three or four firms, hears the right vocabulary, and signs with the one that feels most confident in the room.

Confidence is not the same as capability. And vocabulary is not the same as understanding.

The six questions above work because they're not answerable by reading a medtech trade publication. They require operational experience. You either know what it feels like to build a market before there's a market, or you don't.

MarketCraft was built around this exact gap. Not around campaign execution. Around market engineering. The market engineering framework we use with founders is a direct response to the failure mode these six questions are designed to catch.

And if you're past FDA clearance and haven't yet defined your category, start with the medtech commercialization strategy before you hire any agency. The agency search is a downstream decision. Category design comes first.

Frequently Asked Questions

What Is a Medtech Marketing Agency?

A medtech marketing agency is a firm that specializes in commercial strategy, market narrative, and revenue growth for medical device and digital health companies.

Unlike general healthcare marketing agencies, a true medtech marketing agency understands the regulatory environment, clinical adoption dynamics, VAC and IDN procurement, and the difference between clinical validation and commercial traction.

How Do You Choose a Medtech Marketing Agency for a Startup?

For a medtech startup, the critical filter is pre-traction experience. Ask whether the agency has worked with companies before commercial adoption, how they approach clinical champion development, and whether they understand the traction gap.

Agencies that describe their work only in terms of content calendars, impressions, and follower growth haven't built markets from scratch. They've promoted markets that already existed.

What Should a Medtech Marketing Agency Know About the Traction Gap?

The traction gap is the period between FDA clearance and commercial adoption, where clinical validation exists but market traction hasn't followed. A real medtech marketing agency knows you can't push-market your way through it.

You have to engineer the market narrative, build clinical conviction among early adopters, and sequence market engineering before scaling the sales team.

How Much Does a Medtech Marketing Agency Cost?

Medtech marketing agencies typically range from $8,000 to $40,000 per month, depending on scope, team size, and whether the engagement includes market engineering strategy or only campaign execution.

The cost of hiring the wrong agency, in lost runway, delayed investor conviction, and stalled procurement cycles, typically exceeds the retainer cost by a significant margin.

Listen to the Full Episodes

Omar Khateeb covers medtech commercialization, market engineering, and the commercialization gaps that stall most founders across The State of MedTech.

• How Medtech Startups Drive Technology Adoption to Cross the Chasm and Scale - April 22, 2026
• MRI-native robotic platform for prostate cancer with Fazila Seker, CEO of Insight Medbotics - May 11, 2026

Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.

He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.